Lifestyle Physical Activity for People With COPD

September 22, 2017 updated by: Janet L. Larson, University of Michigan
The purpose of this preliminary study is to examine the effects of a program that includes two-months of structured lab-based training. The proposed study will examine the effects of a lifestyle physical activity intervention designed to increase PA in people with moderate and severe COPD. The intervention includes a combination of (a) structured laboratory-based exercises with a behavioral intervention, (b) structured home-based exercises and (c) lifestyle physical activities performed at home. The subjects will be followed for a total of 18 weeks.

Study Overview

Status

Completed

Conditions

Detailed Description

People with chronic obstructive pulmonary disease (COPD) experience a gradual decline in physical activity (PA). Exercise training in a structured pulmonary rehabilitation program can generate substantial gains in functional capacity, but increases in functional capacity do not necessarily lead to improvements in daily PA. The proposed study will examine the effects of a lifestyle physical activity intervention designed to increase PA in people with moderate and severe COPD. The intervention includes a combination of (a) structured laboratory-based exercises with a self-efficacy enhancing intervention, (b) structured home-based exercises and (c) lifestyle physical activities performed at home. The intervention gradually transitions subjects from the structured laboratory-based exercises that focus on walking and circuit training to fully integrated lifestyle physical activities that integrate structured home-based exercises and lifestyle physical activities into daily life. The purpose of this preliminary study is to examine the effects of a program that includes two-months of structured lab-based training and subjects will be followed for a total of 18 weeks.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan - School of Nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 55 years or older
  • Moderate to severe COPD (FEV1 < 80% and > 30% predicted; FEV1/FVC <70%) as the primary health problem
  • Sedentary (less than 30 minutes of moderate activity 3 days/week)

Exclusion Criteria:

  • No acute exacerbations or major illnesses requiring hospitalization in the last 8 weeks.
  • No history of other major lung diseases as primary pulmonary problem, history of a recent heart attack or recent onset of chest pains with activity or increasing episodes of chest pain (unstable angina).
  • No other health problems or mobility problems that limit physical activity.
  • No child bearing potential

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 8 week group
Lifestyle physical activity self-efficacy
Subjects will come into an exercise lab 2 days per week and perform 10-20 minutes of walking, 13 strength training exercises, stretching and a behavioral intervention including goal setting, etc.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in physical activity measured by accelerometry
Time Frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Subjects wear two activity monitors for seven consecutive days (Actipal and Actigraph). The study will compare the subject's activity level at the three time points listed.
During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in 6 minute walk test
Time Frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Subjects complete a 6 minute walk test measuring the total distance he/she can walk in 6 minutes at the three time points listed.
During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Change in lower extremity function (Short Physical Performance Battery)
Time Frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Subjects complete a performance test measuring balance, gait speed, and leg strength (using a chair stand test) at the three time points listed.
During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Change in dyspnea and fatigue (Pulmonary Functional Status and Dyspnea Questionnaire-Modified)
Time Frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Subjects complete a questionnaire answering questions about their level of dyspnea in various daily activities at the three time points listed.
During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Change in physical activity measured by CHAMPS questionnaire
Time Frame: During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18
Subjects fill out a questionnaire of their perceived physical activity at the three time points listed.
During initial visit (week 1), at 6 or 10 weeks (depending on group placement), and at week 18

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Janet Larson, PhD, University of Michigan - School of Nursing

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2011

Primary Completion (Actual)

July 1, 2017

Study Completion (Actual)

July 1, 2017

Study Registration Dates

First Submitted

May 9, 2013

First Submitted That Met QC Criteria

May 14, 2013

First Posted (Estimate)

May 17, 2013

Study Record Updates

Last Update Posted (Actual)

September 26, 2017

Last Update Submitted That Met QC Criteria

September 22, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • HUM00038130

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COPD

Clinical Trials on Lifestyle physical activity - self-efficacy

Subscribe